BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,220,130 | +1054.6% | 376,792 | +1293.9% | 0.01% | +1000.0% |
| Q2 2023 | $1,231,578 | -96.5% | 27,032 | -96.9% | 0.00% | -96.4% |
| Q1 2023 | $35,148,064 | -45.4% | 873,187 | -30.8% | 0.03% | -47.2% |
| Q4 2022 | $64,343,202 | -5.3% | 1,262,374 | +0.1% | 0.05% | -11.7% |
| Q3 2022 | $67,911,000 | +10.8% | 1,260,883 | +32.1% | 0.06% | +20.0% |
| Q2 2022 | $61,313,000 | +3673.1% | 954,572 | +4457.3% | 0.05% | +4900.0% |
| Q1 2022 | $1,625,000 | -48.2% | 20,946 | -42.6% | 0.00% | -50.0% |
| Q4 2021 | $3,135,000 | -66.9% | 36,512 | -69.0% | 0.00% | -66.7% |
| Q3 2021 | $9,480,000 | -88.0% | 117,861 | -88.0% | 0.01% | -88.9% |
| Q2 2021 | $78,989,000 | +4072.7% | 981,232 | +4272.5% | 0.05% | +5300.0% |
| Q1 2021 | $1,893,000 | +83.6% | 22,441 | +74.7% | 0.00% | 0.0% |
| Q4 2020 | $1,031,000 | -99.0% | 12,849 | -99.0% | 0.00% | -98.9% |
| Q3 2020 | $107,362,000 | -48.1% | 1,335,022 | -44.5% | 0.10% | -51.5% |
| Q2 2020 | $206,933,000 | +10.2% | 2,403,398 | +3.9% | 0.20% | -12.5% |
| Q1 2020 | $187,857,000 | -23.0% | 2,313,793 | -20.7% | 0.22% | -3.4% |
| Q4 2019 | $243,873,000 | +11.3% | 2,916,445 | +16.4% | 0.23% | +5.5% |
| Q3 2019 | $219,167,000 | +6.6% | 2,505,626 | -0.2% | 0.22% | +7.3% |
| Q2 2019 | $205,645,000 | +150.1% | 2,510,922 | +148.3% | 0.20% | +147.0% |
| Q1 2019 | $82,219,000 | +1448.7% | 1,011,179 | +1153.6% | 0.08% | +1283.3% |
| Q4 2018 | $5,309,000 | -15.2% | 80,662 | -0.7% | 0.01% | 0.0% |
| Q3 2018 | $6,259,000 | -45.2% | 81,192 | -47.5% | 0.01% | -45.5% |
| Q2 2018 | $11,419,000 | -16.1% | 154,644 | -26.1% | 0.01% | -21.4% |
| Q1 2018 | $13,605,000 | -85.1% | 209,179 | -85.2% | 0.01% | -84.6% |
| Q4 2017 | $91,484,000 | -18.6% | 1,415,277 | -21.0% | 0.09% | -20.2% |
| Q3 2017 | $112,432,000 | -46.6% | 1,791,739 | -48.5% | 0.11% | -47.7% |
| Q2 2017 | $210,726,000 | -9.0% | 3,480,777 | -22.1% | 0.22% | -9.5% |
| Q1 2017 | $231,648,000 | +1.7% | 4,466,790 | -13.0% | 0.24% | -1.6% |
| Q4 2016 | $227,697,000 | -29.9% | 5,135,256 | -24.7% | 0.24% | -31.4% |
| Q3 2016 | $324,773,000 | -6.4% | 6,822,953 | -11.1% | 0.36% | -9.4% |
| Q2 2016 | $347,033,000 | +13.4% | 7,674,336 | +3.0% | 0.39% | +10.4% |
| Q1 2016 | $306,150,000 | +39.0% | 7,452,528 | +29.1% | 0.36% | +38.4% |
| Q4 2015 | $220,238,000 | +66841.6% | 5,772,953 | +57474.1% | 0.26% | – |
| Q3 2015 | $329,000 | -8.9% | 10,027 | +94.2% | 0.00% | – |
| Q2 2015 | $361,000 | -98.5% | 5,162 | -98.5% | 0.00% | -100.0% |
| Q1 2015 | $23,736,000 | -3.6% | 346,508 | +3.2% | 0.03% | -7.1% |
| Q4 2014 | $24,619,000 | +6180.4% | 335,913 | +6043.3% | 0.03% | – |
| Q3 2014 | $392,000 | +22.9% | 5,468 | +23.8% | 0.00% | – |
| Q2 2014 | $319,000 | -67.7% | 4,417 | -68.9% | 0.00% | -100.0% |
| Q4 2013 | $989,000 | -94.5% | 14,218 | -94.5% | 0.00% | -95.8% |
| Q2 2013 | $17,920,000 | – | 258,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |